StonvexLoading…
StonvexStonvexStonvexCore line items from ETR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-07-28 | Q3 2024 2024-09-30 | Q2 2024 2024-06-30 | Q1 2024 2024-03-31 | Annual 2023 2023-12-31 |
|---|---|---|---|---|---|
Revenue | $3.64B | $9.14B | $5.75B | $2.79B | $12.15B |
Operating Income | Not available | $1.98B | $855.61M | $237.98M | $2.62B |
Net Income | Not available | $774.02M | $51.73M | $76.54M | $2.36B |
EPS (Diluted) | $1.15 | $1.79 | $0.29 | $0.18 | $5.55 |
Total Assets | Not available | $64.46B | $62.77B | $61.63B | $59.70B |
Total Liabilities | Not available | Not available | Not available | Not available | Not available |
Cash & Equivalents | Not available | $1.41B | $1.36B | $1.29B | $132.55M |
Free Cash Flow OCF − CapEx | Not available | $-156.03M | $-577.82M | $-440.06M | $-146.32M |
Shares Outstanding | Not available | 429.47M | 428.31M | 427.75M | 424.75M |